|
|
Volumn 11, Issue 3, 2010, Pages 211-
|
|
New hope for advanced gastric cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
LAPATINIB;
TRASTUZUMAB;
ADVANCED CANCER;
CANCER GROWTH;
CANCER INCIDENCE;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIET THERAPY;
EDITORIAL;
HUMAN;
LIFESTYLE MODIFICATION;
ONCOGENE NEU;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RISK FACTOR;
STOMACH CANCER;
ANTIBODIES, MONOCLONAL;
DRUG APPROVAL;
EUROPE;
HUMANS;
RECEPTOR, ERBB-2;
STOMACH NEOPLASMS;
|
|
EID: 77349095475
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(10)70046-2 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|